Noopept (omberacetam)
Omberacetam: a small molecule built from a two-amino-acid (dipeptide) backbone, used as a nootropic tablet. Related to piracetam but taken in milligrams.
Prescription drug in Russia; not approved in the US or EU (sold online as a supplement).
Used for
- Memory and focus
- Mild cognitive problems after stroke or head injury (Russia)
How it works
Thought to raise BDNF and NGF (nerve growth signals) and act on AMPA and acetylcholine signaling; it is converted to cycloprolylglycine, a natural brain peptide.
What the research shows
- A Russian trial in mild cognitive disorders after vascular disease or head injury compared it with piracetam and found similar benefit with fewer side effects.
- A small Russian study in post-stroke mild cognitive impairment reported benefit; trials are small and none are from outside Russia.
Dosing
Dosing isn’t listed on the public site. In the app, each published option is shown with its source (a drug label, a clinical guideline, a trial or community reports) and can be turned into a protocol you review.
Work out the units to draw for your vial →Side effects
- Irritability, trouble sleeping if taken late
- Headache
- Can raise blood pressure in people with hypertension
Cautions
- Unregulated outside Russia: products sold as supplements vary in content.
- No long-term safety data.
Storage
Unmixed powder: freezer or fridge, away from light.
Once mixed with bacteriostatic water: fridge; the common rule is to use it within 28 days.
There is no label or published stability data for this one, so treat these as habits, not limits.
Reference only, not medical advice. Written for this app from the cited research. Doses marked community-reported are not from trials.